GlobalData on MSN7d
Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Sanofi to sell 50% stake in consumer health unit to CD&R
Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...
Drug Store News7d
Sanofi nears selling 50% controlling stake in Opella to CD&R
Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton ...
Press Release: Sanofi and CD&R sign Opella share purchase agreement
Sanofi and CD&R sign Opella share purchase agreementParis, February 19, 2025. Following completion of the required social and corporate ...
Banks on the Hook for Sanofi Buyout Face Agonizing Wait to Sell
Deal-starved banks lined up to make concessions to get a slice of Europe’s biggest buyout debt deal last year. They also put ...
Reuters27d
Sanofi plans share buybacks, signals more deals post Opella sale
The sale of Sanofi's controlling stake in health business Opella is expected to close in the second quarter at the earliest, completing its transition into a pure-play drug and vaccine manufacturer.
Business Insider29d
Sanofi’s Promising Future: Buy Rating Backed by Strategic Moves and Strong Pipeline
Despite the anticipated reduction in earnings per share for late 2024 and 2025 due to the exit of the Opella consumer business, Risinger remains optimistic about Sanofi’s growth potential.
Daily5d
Sanofi nears selling 50 percent controlling stake in Opella to CD&R
Paris: Sanofi and CD&R have announced that they have signed the share purchase agreement in relation to the sale of a 50 ...